Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001096
Status:
COMPLETED
Last Update Posted:
2021-11-04
First Post:
1999-11-02
Brief Title:
A Phase I Multicenter Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX BE HIV-1 MN rgp120A244 rgp120 in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults
Sponsor:
Organization:
National Institute of Allergy and Infectious Diseases NIAID